Skip to Content

GG 537 (Bromocriptine Mesylate 5 mg)

Pill with imprint GG 537 is White & Yellow, Capsule-shape and has been identified as Bromocriptine mesylate 5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Bromocriptine is used in the treatment of diabetes, type 2; acromegaly; hyperprolactinemia; parkinson's disease; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 537

Bromocriptine mesylate

GG 537
5 mg
White & Yellow
16.00 mm
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Prolactin inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
magnesium stearate
ferric oxide red
sodium lauryl sulfate
corn starch
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.